The Washington Times reported on February 22 that Medical Marijuana Delivery Systems LLC (MMDS) announced it had acquired the U.S. Patent rights to the Medical Marijuana Patch, guaranteeing the company exclusive rights for development of the Patch for transcutaneous (meaning medications applied through the skin) delivery of medical marijuana to humans and animals.
Marketed under the trademark TETRACAN, medical marijuana dispensaries countrywide will most likely sell the Patch by year’s end.
No comments:
Post a Comment